VAXX Vaxxinity
- 0.120
- +0.003+2.92%
Vaxxinity News
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS guidance.
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersCatheter Precision (AMEX:VTAK) shares moved upwards by 27.8% to $0.58 during Wednesday's regular session. The company's market cap stands at $4.4 million. Prenetics Global (NASDAQ:PRE) stock mo
Why Vaxxinity (VAXX) Shares Are Volatile Today
Vaxxinity Inc (NASDAQ:VAXX) shares are trading lower by 10% to $0.24 during Tuesday's session. The stock is trading lower on continued volatility after the company announced its intention to voluntari
Phio PHIO Preclinical Data; Vaxxinity VAXX Delisting NASDAQ
Why Vaxxinity (VAXX) Shares Are Down Nearly 50%
Vaxxinity Inc (NASDAQ:VAXX) shares are trading lower by 47% to $0.25 during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.Thi
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.
Sector Update: Health Care Stocks Advance Premarket Monday
Health care stocks were advancing premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was up 0.5% and the iShares Biotechnology ETF (IBB) was 0.8% higher recently. Vaxxinity (VAXX) was r
Vaxxinity VAXX Delisting; Hepion HEPA Trial Wind-down
Express News | Vaxxinity Shares Are Trading Lower After the Company Announced Its Intention to Voluntarily Delist and Deregister Its Class A Common Stock
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersAdial Pharmaceuticals (NASDAQ:ADIL) stock rose 34.2% to $2.59 during Monday's pre-market session. The company's market cap stands at $10.5 million. NKGen Biotech (NASDAQ:NKGN) shares moved upwa
Why Riot Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Riot Platforms, Inc. (NASDAQ:RIOT) rose sharply in today's pre-market trading amid a rise in Bitcoin.Bitcoin (CRYPTO: BTC) prices gained around 1.5% over the past 24 hours to $66,012 this mo
Vaxxinity Issues Shareholder Letter
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. ("Vaxxinity", "we", "us" or the "Company") (NASDAQ:VAXX), a U.S. company pioneering the development of a new class of medicines, today announced
Vaxxinity to Voluntarily Delist From Nasdaq; Shares Sink After Hours
Vaxxinity (VAXX) shares plunged nearly 35% in extended hours Friday after disclosing plans to voluntarily delist from the Nasdaq Global Market next month. The specialty drugmaker said it notified Nasd
12 Health Care Stocks Moving In Friday's After-Market Session
GainersMobile-health Network (NASDAQ:MNDR) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. Galera Therapeutics (NASDAQ:GRTX) stock in
Express News | Vaxxinity Announces Intention To Voluntarily Delist Class A Common Stock From Nasdaq
Express News | Vaxxinity: Expects Class a Common Stock to Initially Be Quoted on Market Operated by Otc Markets Group
Express News | Vaxxinity Inc - Notified Nasdaq of Its Intent to Voluntarily Delist Its Class a Common Stock From Nasdaq
Express News | Vaxxinity Announces Intention to Voluntarily Delist and Deregister Its Class a Common Stock
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
The AAN Annual Meeting is the largest gathering of neurologists and neuroscience professionals and offers top-tier education, the latest in scientific discoveries, and an abundance of opportunities to connect with friends and colleagues from around the globe.
Vaxxinity GAAP EPS of -$0.09
Analysis
Price Target
No Data
